ABOS · Acumen Pharmaceuticals, Inc.
SELL 89%
76
Total trades
14
Insiders on record
89%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Jan 8, 2026 | Derek M Meisner | SELL | Open-market sale | 12.4K | 0.89 |
| Jan 7, 2026 | Matt Zuga | SELL | Open-market sale | 8.2K | 0.93 |
| Jan 7, 2026 | Derek M Meisner | SELL | Open-market sale | 3.4K | 0.84 |
| Jan 6, 2026 | Derek M Meisner | SELL | Open-market sale | 14K | 0.85 |
| Jan 23, 2025 | Matt Zuga | SELL | Open-market sale | 49.6K | 0.96 |
| Jan 21, 2025 | Derek M Meisner | SELL | Open-market sale | 5.4K | 0.84 |
| Jan 21, 2025 | Matt Zuga | SELL | Open-market sale | 7K | 0.92 |
| Jan 21, 2025 | Daniel Joseph Oconnell | SELL | Open-market sale | 20.1K | 0.94 |
| Jan 21, 2025 | Russell Barton | SELL | Open-market sale | 4.7K | 0.91 |
| Jan 21, 2025 | Eric Siemers | SELL | Open-market sale | 5.1K | 0.88 |
Acumen Pharmaceuticals, Inc. has 76 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade ABOS?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.